Display options
Cite
Mandala E, Lafaras C, Goulis I, et al. Treatment of a patient with classical paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome, with complement inhibitor eculizumab: Case Report. Hippokratia. 2013;17(1):81-4
Mandala, E., Lafaras, C., Goulis, I., Tsioni, K., Georgopoulou, V., & Ilonidis, G. (2013). Treatment of a patient with classical paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome, with complement inhibitor eculizumab: Case Report. Hippokratia, 17(1), 81-4.
Mandala, E, et al. "Treatment of a patient with classical paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome, with complement inhibitor eculizumab: Case Report." Hippokratia vol. 17,1 (2013): 81-4.
Mandala E, Lafaras C, Goulis I, Tsioni K, Georgopoulou V, Ilonidis G. Treatment of a patient with classical paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome, with complement inhibitor eculizumab: Case Report. Hippokratia. 2013 Jan;17(1):81-4. PMID: 23935352; PMCID: PMC3738287.
Copy Download .nbib Format: NLM
Share it on

Hippokratia. 2013 Jan;17(1):81-4.

Treatment of a patient with classical paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome, with complement inhibitor eculizumab: Case Report.

Hippokratia

E Mandala, C Lafaras, I Goulis, K Tsioni, V Georgopoulou, G Ilonidis

Affiliations

  1. Fourth Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippokratio Hospital, Thessaloniki, Greece.

PMID: 23935352 PMCID: PMC3738287

Abstract

Background. Paroxysmal nocturnal haemoglobinuria (PNH) is a rare acquired clonal disorder of hematopoietic stem cells involving all blood cells. Erythrocytes have increased susceptibility to complement-mediated haemolysis. Thrombosis is the leading cause of mortality and follows episodes of acute hemolysis. Eculizumab, a monoclonal antibody blocking activation of complement C5 is currently used in the treatment of PNH. Recent results demonstrated that eculizumab effectively reduces thrombosis. Description of case. We present a 30-year-old male patient admitted with abdominal and lumbar pain. Thorough investigation revealed severe hemolytic anemia requiring transfusions and hepatosplenomegaly. Imaging findings were compatible with a Budd-Chiari syndrome. Flow cytometry confirmed the PNH diagnosis. Due to refractory ascites he underwent a transjugular intrahepatic portal-systemic shunt (TIPS) and eculizumab administration was started. Results. He has already completed three years of eculizumab treatment and he is transfusion independent. There is also a significant reduction in fatigue with improvement in his quality of life. Doppler scans of his TIPS persistently show it to be patent. Conclusions. Classical PNH patients with thrombosis and severe intravascular hemolysis are particularly challenging to manage. For these patients, eculizumab is a reasonable therapeutic option, expecting that by decreasing the risk for thrombosis, life expectancy may be increased.

Keywords: Budd-Chiari syndrome; Paroxysmal nocturnal haemoglobinuria (PNH); eculizumab

References

  1. Blood. 2005 Dec 1;106(12):3699-709 - PubMed
  2. Hepatology. 2003 Oct;38(4):793-803 - PubMed
  3. J Thromb Haemost. 2006 May;4(5):1114-24 - PubMed
  4. N Engl J Med. 2006 Sep 21;355(12):1233-43 - PubMed
  5. Lancet. 1996 Aug 31;348(9027):573-7 - PubMed
  6. Blood. 2008 Feb 15;111(4):1840-7 - PubMed
  7. N Engl J Med. 2004 Feb 5;350(6):578-85 - PubMed
  8. J Vasc Interv Radiol. 2006 Feb;17(2 Pt 1):383-7 - PubMed
  9. Blood. 2007 Dec 1;110(12):4123-8 - PubMed
  10. Haematologica. 1996 Nov-Dec;81(6):540-2 - PubMed
  11. Clin Adv Hematol Oncol. 2012 Jun;10(6):391-3 - PubMed
  12. Immunobiology. 2012 Nov;217(11):1080-7 - PubMed
  13. JAMA. 2005 Apr 6;293(13):1653-62 - PubMed
  14. Hepatology. 2002 Jan;35(1):132-9 - PubMed
  15. Cytometry. 2000 Aug 15;42(4):223-33 - PubMed
  16. Blood. 2008 Oct 15;112(8):3099-106 - PubMed
  17. J Gastroenterol Hepatol. 2013 Jan;28(1):148-52 - PubMed
  18. N Engl J Med. 2004 Feb 5;350(6):552-9 - PubMed
  19. N Engl J Med. 1995 Nov 9;333(19):1253-8 - PubMed
  20. Am J Hematol. 2009 Oct;84(10):699-701 - PubMed
  21. Blood. 2006 Mar 1;107(5):2131-7 - PubMed
  22. Hepatology. 1998 Apr;27(4):1157-61 - PubMed
  23. Blood. 2009 Jun 25;113(26):6522-7 - PubMed

Publication Types